FINGOLIMOD (has an active metabolite) | FINGOLIMOD | ATC L04AA27
IMMUNOMODULATING IMMUNOSUPPRESSANT MULTIPLE SCLEROSIS FINGOLIMOD IS METABOLIZED BY SPHINGOSINE KINASE TO THE ACTIVE METABOLITE FINGOLIMOD-PHOSPHATE FINGOLIMOD-PHOSPHATE INVOLVES REDUCTION OF LYMPHOCYTE MIGRATION INTO THE CENTRAL NERVOUS SYSTEM S1P1 MODULATOR (RECEPTOR DEGRADATION VERSUS RECYCLING TO CELL SURFACE) | ORAL | F 93 PERCENT PPB 99.7 PERCENT SOLUBILITY FREELY SOLUBLE IN WATER | SPHINGOSINE 1-PHOSPHATE RECEPTOR (S1P1) | SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST CHEMBL2363041 SPHINGOSINE 1-PHOSPHATE RECEPTOR O95136 SPHINGOSINE 1-PHOSPHATE RECEPTOR 2 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL LIPID-LIKE LIGAND RECEPTOR EDG RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |